You are here

On Jan 28, 2019 at Meeting room no.1, Office of the Dean, Prof.Piyamitr Sritara, Dean of Faculty of Medicine Ramathibodi Hospital, Mahidol University, along with the board of executives provided the warm welcome for Sir David Sloman, the NHS Regional Director for London, UK; and his team. The purpose of this visit are for giving special lecture on Management of Health Service System in London and having hospital site visit as well as for looking for the possible collaboration between Ramathibodi and NHS, London.

On January 31, 2019 at the Research Center's meeting room, Faculty of Medicine Ramathibodi Hospital, Mahidol University; Prof. Wichai Aekplakorn, Head of Department of Community Medicine, along with his research team including Dr. Anchalee Chittamma and her four research assistants and Dr. Surasak Kantachuvesiri, chairman of the Low Salt Thailand Network kindly welcomed the visitors from Resolve to Save Lives, US-CDC, and WHO on occasion of their visit at Ramathibodi.

 

 

 

The purpose of this visit is to observe the laboratory equipment for serum trans fatty acid analysis and to discuss with Prof. Wichai Aekplakorn and Dr.Anchalee Chittamma on serum trans fat analysis and sodium surveillance with the experts from Resolve to save lives, US-CDC and WHO.

 

During January 23rd - 25th, 2019; Prof. Boonsong Ongphiphadhanakul, MD, Deputy Dean for Research, Faculty of Medicine Ramathibodi Hospital, along with Asst. Prof. Suchin Worawichawong, MD, Assistant Dean for International Relations; Prof. Dr. Wasun Chantratita, PhD, Head of Center for Medical Genomics, and Dr.Jakris Eu-ahsunthornwattana, MD, PhD Faculty Member of Department of Community Medicine attended Cotutelle & Joint PhD 2019 International Research Training Partnerships Workshop at Macquarie University, Australia; as the representatives of Faculty of Medicine Ramathibodi Hospital, Mahidol University. On this occasion, Prof. Dr. Wasun Chantratita, PhD had been invited as the speaker for “Over 1,000 EGAT participants in ‘game-changing’ Thailand Genomes Project”; while Dr.Jakris Eu-ahsunthornwattana, MD, PhD joined as speaker for “Genomics Thailand and population genomics research in Ramathibodi Hospital”.

The objective of this visit is to introduce foreign universities’ executive board members of Mahidol University, and professionals the new strategic plan of Thailand higher education, and to strengthen cooperation between MU & MQ in particular for the pioneering field of genomic research and related collaboration further, following the EEC’s aspiration.

On November 30, 2018 at Meeting Room 2, Office of the Dean, Prof. Duangrurdee Wattanasirichaigoon, M.D., Deputy Dean for Graduate Education; along with Asst. Prof. Wantana Maneesriwongul , Deputy Director for for Academic and International Relations, Ramathibodi School of Nursing; Asst. Prof. Smith Srisont, M.D., Assistant Dean for Student Affairs; Asst. Prof. Natini Jinawath, M.D., Assistant Dean for Graduate Education; and Dr. Meng-Shin Shiao, Assistant Dean for International Relations, as the representatives of the Dean and the faculty's executives, precisely provided kind welcome to the group of visitors from Kunming Medical University, led by the executives such as Prof. Wu Xinan, Vice Dean of Graduation School; Assoc. Prof. LI Bo, Chief of Section of General Affairs, Graduation School; Assoc. Prof. LIU Jianxing, Chief of Section of Academic Affairs, Graduation School, on the occasion of their revisit the Faculty of Medicine Ramathibodi Hospital, Mahidol University. 

The proposes of their visit are to have collaborative discussion towards several issues such as Short course training in Nursing, How to control infectious especially in rural areas, and the possibility of students exchange activities; both for Undergrad and Postgrad, between the 2 institutes.

The proposes of their visit are to have collaborative discussion towards several issues such as Short course training in Nursing, How to control infectious especially in rural areas, and the possibility of students exchange activities; both for Undergrad and Postgrad, between the 2 institutes.

Assoc. Prof.Wasun Chantratita, M.D.,Head of Center for Medical Genomics, provided warm welcome to Netherlands Task Force Health Care (TFHC) led by Mr. Peter Post, Director; to visit Ramathibodi's Center for Medical Genomics and have discussion towards possibility of collaboration.

Task Force Health Care (TFHC) is a public-private platform founded in 1996. The TFHC network consist of partners from industry, knowledge institutes, NGO’s, healthcare providers and the government, all active in the Dutch Life Sciences & Health sector. The partners provide innovative and sustainable solutions to global (and local) healthcare challenges and are active all over the world. In the last decade the TFHC visited and maintained relationships with more than 30 countries. Through the implementation of Country Platforms the TFHC created a sustainable & special focus on: China, India, Indonesia, Russia, the Middle East and Africa.

 

 

 

On Nov.27, 2018 at The Dean’s Meeting Room, Office of the Dean, 5th Floor of Lecture Hall Building, Faculty of Medicine Ramathibodi Hospital, Mahidol University; Prof.Piyamitr Sritara, M.D., Dean, following with his Assistant Dean for International Relations, Assoc. Prof.Sirin Apiyasawat, M.D., Dr.Tachapong Ngarmukos, M.D., Head of Cardiovascular & Metabolic Center and Asst. Prof.Pavit Pienvichit, M.D. from Division of Cardiology, Department of Medicine; organized an official welcome for the distinguished visitors from Boston scientific corporation, leading by Mr. Michael Mahoney who is the Chairman & CEO and his Senior Vice President &  President of Asia Pacific, Mr. Warren Wang.

The purpose of their visit are to discuss about the possibility to establish a collaborative excellence center for Arrhythmia care with Rhythmia 3D navigation system and have several site visits to the working areas in Ramathibodi including Department of Diagnostic Radiology’s Body Intervention Unit, Cardiac Catheterization Laboratory and Coronary Care Unit and Somdech Phra Debaratana Medical Center.

Boston Scientific Corporation is one of the world's leaders in the medical devices industry, developing, manufacturing and marketing sophisticated medical devices worldwide world WITH turnover in excess of US$2 billion.

On November 9, 2018 - Prof.Sirintara Singhara Na Ayudhaya, M.D., Deputy Dean for International Relations along with her Assistant Dean for International Relations; Assist.Prof.Suchin Worawichawong, M.D. Assoc. Prof. Krisna Lertsukprasert; Head of Department of Communication Sciences and Disorders, as well as the specialists, instructors and professional staff of the department, precisely welcomed the Executive Director, Research Training and International Research Training Partnerships of Macquarie University, Australia, Dr. Ren Yi.

The meeting included a lively discussion and a commitment to more research exchanges and possibility to do the duo program between the 2 institutes in the area of Audiology & Speech-Pathology. Macquarie University is a public research university located in Sydney, Australia. It has 40,000 students, a quarter of which are graduate students. Although relatively young - it was founded in 1964 - it ranks highly among universities within Australia and around the world.

At Meeting Room no.2, Office of the Dean, Faculty of Medicine Ramathibodi Hospital, Prof. Piyamitr Sritara, Dean of Faculty of Medicine together with Mr. Jason Anderson, Chief Executive Officer of Liberty Biosecurity, LLC and Mr. Marek Stepniak, President of CP Medical Center Co., Ltd., signed the Memorandum of Understanding on behalf of their respective cooperates on November 14, 2018.

The MOU contains a detailed framework for cooperation in research developing and analyzing a unique dataset for cancer research including Cancer Sequencing , Digital Pathology Imaging, Additional Data Collection, finally, the Data Analysis of databases and population studies.

Nov 7, 2018, Prof.Piyamitr Sritara, Dean of Faculty of Medicine Ramathibodi Hospital, along with Prof. Sirintara Singhara Na Ayudhaya, M.D., Deputy Dean for International Relations, Prof.Ammarin Thakkinstian, Ph.D. Head, Section for Clinical Epidemiology and Biostatistics and the team of Lecturers provided the warm welcome to Prof. Rebessa Ivers, M.D. Head, School of Public Health and Community Medicine, University of New South Wales precisely visited Faculty of Medicine Ramathibodi Hospital, Mahidol University in order to provide special lecture on "Research on Trauma and Accidents" for Ramathibodi's young staff and PhD students in program of Clinical Epidemiology and Biostatistics and discuss for any possible research collaboration between the 2 institutes.

Oct 30, 2018 at Meeting room No.1, Office of the Dean; Piyamitr Sritara, Dean, along with Assoc. Prof.Sirin Apiyasawat, M.D., Assistant Dean for International Relations, Assist. Prof. Smith Srisont, M.D., Assistant Dean for Student Affairs and Assist. Prof. Natinee Jinawat, M.D., Assistant Dean for Graduate Education, precisely provided a welcome to the 4 executives from Kansai Medical University including Prof.Koichi Tomoda, M.D. President, Prof.Yuko Suzuka, M.D. Director for International Exchange, Prof.Toshimasa Nishiyama, M.D., DMSc and Hirotake Mori, M.D., DTMH, Ph.D., on their occasion of visit the Faculty of Medicine Ramathibodi Hospital, Mahidol University, in order to achieve the MOU signing ceremony between the 2 institutes.

Kansai Medical University (KMU) is a private medical university in the city of Moriguchi, situated in Osaka Prefecture, a satellite town of Osaka, Japan. Its origins can be traced back to 1928, when the Osaka Women’s Medical College was established, but it was not chartered until 1947. In the same year, College Hospital, the first KMU affiliated hospital was established, and an affiliated nursing school was established the following year. KMU became co-educational in 1954, when it was upgraded to the status of an incorporated educational institution and was given the name it has today. KMU has four affiliated hospitals, including KMU Kori Hospital, KMU Medical Centre, which has a Cardiovascular Centre, and KMU University Hospital, which has a Tertiary Emergency and Critical Care Centre, as well as Kansai Medical University Temmabashi General Clinic.

On October 22, 2018, the signing ceremony for General Agreement between the Faculty of Medicine Ramathibodi Hospital, Mahidol University, Thailand and University of South Florida (USF) was held at Meeting Room no.2, Office of the Dean, Lecture Hall. The Agreement between Ramathibodi andUSF is aimed to establish the official collaboration between the 2 institutes which leads to the further fruitful exchange activities. By the ceremony, the speeches were delivered by Prof. Piyamitr Sritara, M.D., FRCP, FACP,FRCP(T),Dean of Ramathibodi, and Prof.John Sinnot, Chairman of Internal Medicine, University of South Florida; as representatives of each institutes. On this occasion, Prof. Sirintara Singhara Na Ayudhaya, M.D, Deputy Dean for International Relations,the other delegates from both institutes including Dr. Teerapat Yingchoncharoen, M.D., Assistant Dean for Education and Research; Dr. Visasiri Tantrakul, M.D., Medical Instructor in Division of Pulmonary and Critical Care, Department of Medicine and Assistant Professor Monvasi Pachinburavan, M.D. from of Medicine, Pulmonary and Critical Care Medicine of USF, attended as honorable witnesses.

 

The University of South Florida, also known as USF, is an American metropolitan public research university in Tampa, Florida, United States. USF is also a member institution of the State University System of Florida. Founded in 1956, USF is the fourth-largest public university in the state of Florida. The USF system has three institutions: USF Tampa, USF St. Petersburg and USF Sarasota-Manatee.USF is classified by the Carnegie Foundation for the Advancement of Teaching in the top tier of research universities, and is among three other universities in Florida to hold this highest level of classification. The Agreement signed today will facilitate a collaborative process in Joint educational, research activities, exchange of visiting scholars, and also provides an avenue for possibilities of the further student or staff exchange activities between Ramathibodi and USF. 

Bangkok- October 2, 2018– In light of personalized medicine and smart medicine being the trend of next generation medicine, Translational Medicine MSc and PhD Programs together with Division of Postgraduate Study and Division of International Relations at the Faculty of Medicine Ramathibodi Hospital, Mahidol University, hosted The 1st Thailand-Taiwan Forum on Medical Science and Technology, under the theme: “Next-Generation Era of High Throughput Smart Medicine and Personalized Medicine” at the Meeting Room on the 7th floor of Somdetch Phra Debaratana Building.

 

Twelve distinguished speakers from the 2 leading universities of Taiwan including National Sun-Yet Sen University and National Taiwan University joined the symposium. The MSc and PhD Programs in Translational Medicine, Faculty of Medicine Ramathibodi Hospital and College of Sciences, National Sun Yat-sen University has jointly signed the double degree program agreement for both Ph.D. and Master degrees in 2017, which is the first double degree program between Taiwan and Thailand.  Furthermore, Ramathibodi School of Nursing also has long-term collaborations with the National Taiwan University. 

On this occasion, Prof.Sirintara Singhara Na Ayudhaya, M.D., Deputy Dean for International Relations, Faculty of Medicine Ramathibodi Hospital, Mahidol University, as the representative of the Dean, Prof. Duangrurdee Wattanasirichaigoon, M.D., Deputy Dean for Graduate Education, and Dr.Chen-Yuan Tung, Representative of Taipei Economic & Cultural Office in Thailand together welcomed our distinguished speakers.  Prof. Sirintara stated during her remark that Ramathibodi has succeeded in setting up an official collaboration with National Sun Yat-sen University in order to establish the official long-term research collaboration and a Cooperation Agreement for Master and Doctoral Double Degree Programs and also encouraged collaborations of using animal models to study human diseases.  While Dr.Chen-Yuan Tung expressed his willing to promote the exchanges and cooperation in medical education, science and technology between Thailand and Taiwan.  He further mentioned that there are many scholarships provided for Thailand students to study in Taiwan. 

The Panel Sessions during these 2 days scientific forum focused on the following key topics:

· Toxicology

· Animal model

· Regenerative medicine, immunotherapy for cancer and pharmacogenomics

· Pharmacology

· Cancer

We sincerely hope 2018 The 1st Thailand-Taiwan Forum on Medical Science and Technology or-ganized by International Relations Section and Graduate Education Section of the Faculty of Medicine Ramathibodi Hospital, Mahidol Uni-versity provides a structured platform for the young blooded researchers to share information and provide the latest updates on their research projects, particularly on Medical Science and Technology in Smart Medicine and Personalized Medicine.

 

 

 

 

 

Pages